Abstract:Influenza virus infections can cause a broad range of symptoms, form mild respiratory problems to severe and fatal complications. While influenza virus poses a global health threat, the frequent antigenic change often significantly compromises the protective efficacy of seasonal vaccines, further increasing the vulnerability to viral infection. Therefore, it is in great need to employ strategies for the development of universal influenza vaccines (UIVs) which can elicit broad protection against diverse influenza viruses. Using a mouse infection model, we examined the breadth of protection of the caspase-triggered live attenuated influenza vaccine (ctLAIV), which was self-attenuated by the host caspase-dependent cleavage of internal viral proteins. A single vaccination in mice induced a broad reactive antibody response against four different influenza viruses, H1 and rH5 (HA group 1) and H3 and rH7 subtypes (HA group 2). Notably, despite the lack of detectable neutralizing antibodies, the vaccination provided heterosubtypic protection against the lethal challenge with the viruses. Sterile protection was confirmed by the complete absence of viral titers in the lungs and nasal turbinates after the challenge. Antibody-dependent cellular cytotoxicity (ADCC) activities of non-neutralizing antibodies contributed to cross-protection. The cross-protection remained robust even after in vivo depletion of T cells or NK cells, reflecting the strength and breadth of the antibody-dependent effector function. The robust mucosal secretion of sIgA reflects an additional level of cross-protection. Our data show that the host-restricted designer vaccine serves an option for developing a UIV, providing pan-influenza A protection against both group 1 and 2 influenza viruses. The present results of potency and breadth of protection from wild type and reassortant viruses addressed in the mouse model by single immunization merits further confirmation and validation, preferably in clinically relevant ferret models with wild type challenges.

Severe coarctation of the aorta with pulmonary edema. An unusual presentation of a traumatic aortic aneurysm.

Lung Cancer and Indoor Exposure to Coal and Biomass in Rural China

Mouse Models Choosing for the Comparative Study of Different Pathogenic Avian Influenza Viruses

Comparison of three mouse models infected with influenza virus by aerosol

Infection Of Inbred Balb/C And C57bl/6 And Outbred Institute Of Cancer Research Mice With The Emerging H7n9 Avian Influenza Virus

Comparative Pathology of Animal Models for Influenza A Virus Infection

Pulmonary alterations in rats due to acute phosgene inhalation.

Increasing prevalence of childhood overweight and obesity in a coastal province in China

Electrophoretic properties of dodecyltrimethylammonium bromide micelles in KBr solution

Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain

Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice

Health economics in psychiatric nursing.

Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design

A transgenic mouse with a humanised B cell repertoire mounts an antibody response to influenza infection and vaccination

Comparative pathogenicity of influenza virus-induced pneumonia mouse model following intranasal and aerosolized intratracheal inoculation

Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model

An infant mouse model of influenza-driven nontypeable Haemophilus influenzae colonization and acute otitis media suitable for preclinical testing of novel therapies

Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates

The Microrna-Let-7b-mediated Attenuated Strain of Influenza A (H1N1) Virus in a Mouse Model.

A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis